Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer

International Journal of Oncology

Volumn 28, Issue 2, 2006, Pages 297-306

  Iinuma, Hisae ^a   Okinaga, Kota ^a   Egami, Hiroshi ^b   Mimori, Koshi ^c   Hayashi, Naoko ^b   Nishida, Koujiro ^c   Adachi, Miki ^a   Mori, Masaki ^c   Sasako, Mitsuru ^d  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

Author keywords

CEA; CK20; Colorectal cancer; Isolated tumor cells; Liver metastasis; Real time reverse transcriptase polymerase chain reaction; Tumor drainage blood

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CANCER INVASION; CELL STRAIN HT29; COLORECTAL TUMOR; FEMALE; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR EMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HT29 CELLS; HUMANS; KERATIN-20; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 33947505827     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.2.297     Document Type: Article

References (31)

1. Castella A, Kroser J and Rustgi AK: Gastrointestinal neoplasma. In: The Merck Manual of Geriatrics. 3rd edition. Beers MH and Berkow R (eds). West Point: Merck&Co., pp1134-1153, 2000.
2. Safi F and Beyer HG: The value of follow-up of curative surgery of colorectal carcinoma. Cancer Detect Prev 17: 417-424, 1993.
3. Kune GA, Kune S, Field B, White R, Brough W and Schellenberger R: Survival in patients with large-bowel cancer. Dis Colon Rectum 33: 938-946, 1990.
4. Ovaska J, Jarvinen H, Kujari H, Perttila I and Mecklin JP: Follow-up of patients operated on for colorectal carcinoma. Am J Surg 159: 593-596, 1990.
5. Matsumura M, Niwa Y and Kato N: Detection of α-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 20: 1418-1425, 1994.
6. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K and Akiyoshi T: Clinical significance of molecular detection of carcinoma cells in lymph nodes and peritoneal blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinoma. J Clin Oncol 16: 128-132, 1998.
7. Travellas G, Patel H and Allen-Mersh TG: Detection and clinical significance of occult tumor cells in colorectal cancer. Br J Surg 88: 1307-1320, 2001.
8. Wyld D, Selby P, Perren TJ, Jonas SK, Allen-Mersh TG, Wheeldon J and Burchill SA: Detection of colorectal cancer cells in peripheral blood by traverse-transcriptase polymerase chain reaction for cytokeratin 20. Int J Cancer 79: 288-293, 1998.
9. Hardingham JE, Hewett PJ, Sage RE, Finch JL, Nuttall JD, Kotasek D and Dobrovic A: Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer 89: 8-13, 2000.
10. Taniguchi T, Makino M, Suzuki K and Kaibara N: Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma. Cancer 89: 970-976, 2000.
11. Yamaguchi K, Takagi Y, Aoki S, Futamura M and Saji S: Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 232: 58-65, 2000.
12. Bessa X, Elizalde JI, BOIX L, Pinol V, Lacy AM, Salo J, Pique JM and Castells A: Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 120: 1084-1092, 2001.
13. Piva MG, Navaglia F, Basso D, Fogar P, Roveroni G, Gallo N, Zambon C-F, Pedrazzoli S and Plebani M: CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging. Oncology 59: 323-328, 2000.
14. Vlems FA, Ladanyi A, Gertler R, Rosenberg R, Dieostra JHS, Roder C, Nekarda H, Molnar B, Tulassay Z, Muijen GNP and Vogel MI: Reliability of quantitative reverse-transcriptase-PCR-based detection of tumor cells in the blood between different laboratories using a standardized protocol. Eur J Cancer 39: 388-396, 2003.
15. Miyake Y, Fujiwara Y, Ohue M, Yamamoto H, Sugita Y, Tomita N, Sekimoto M, Shiozaki H and Monden M: Quantification of micrometastases in lymph nodes or colorectal cancer using real-time fluorescence polymerase chain reaction. Int J Oncol 16: 289-293, 2000.
16. Nakanishi H, Kodera Y, Yamamura Y, Ito S, Kato T, Ezaki T and Tatematsu M: Rapid quantitative detection of carcinoembryonic antigen-expressing free tumor cells in the peritoneal cavity of gastric-cancer patients with real-time RT-PCR on the LightCycler. Int J Cancer 89: 411-417, 2000.
17. Schuster R, Max N, Mann B, Heufelder K, Thilo F, Grone J, Rokos F, Buhr H-J, Thiel E and Keilholz U: Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int J Cancer 108: 219-227, 2004.
18. Ito S, Nakanishi H, Hirai T, Kato T, Kodera Y, Feng A, Kasai Y, Ito K, Akiyama S, Nakao A and Tatematsu M: Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler. Cancer Lett 183: 195-203, 2002.
19. Miura M, Ichikawa Y, Tanaka K, Kamiyama M, Hamaguchi Y, Ishikawa T, Yamaguchi S, Togo S, Ike H, Ooki S and Shimada H: Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients. Anticancer Res 23: 1271-1276, 2003.
20. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzanigs G, Cayuela JM, Cave H, Pane F, Aerts JL, De Micheli D, Thirion X, Prade V, Gonzales M, Viehmann S, Males M, Saglio G and van Dongen JJ: Standardization and quality control studies of real-time quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 17: 2318-2357, 2003.
21. Olavarria E, Kanfer E, Saydlo R, Kaeda J, Rezvani K, Cwynarski K, Pocock C, Dazzi F, Craddock C, Apperley JF, Cross NC and Goldman JM: Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood 97: 1560-1565, 2001.
22. Iinuma H, Okinaga K, Adachi M, Suda K, Sekine T, Sakagawa K, Baba Y, Tamura J, Kumagai H and Ida A: Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer. Int J Cancer 89: 337-344, 2000.
23. Noguchi S, Aihara T and Nakamori S: The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase- polymerase chain reaction. Cancer 74: 1595-1600, 1994.
24. Neumaier M, Gerhard M and Wagener C: Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 159: 43-47, 1995.
25. Noguchi S, Aihara T and Motomura K: Histologic characteristics of breast cancer with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction. Cancer 78: 1235-1240, 1996.
26. Bessa X, Pinol V, Castelvi-Bel S, Oiazuelo E, Lacy AM, Elizalde JI, Pique JM and Castells A: Prognostic value of post-operative detection of blood circulating tumor cells in patients with colorectal cancer operated on for cure. Ann Surg 237: 368-375, 2003.
27. Aoki S, Takagi Y, Hayakawa M, Yamaguchi K, Futamura M, Kunieda K and Saji S: Detection of peritoneal micrometastases by reverse transcriptase-polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients. J Exp Clin Cancer Res 21: 555-561, 2002.
28. Futamura M, Takagi Y, Komura H, Kida H, Tanemura H, Shimokawa K and Saji S: Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptasepolymer chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol 68: 34-40, 1998.
29. Krisman M, Todt B, Schorder J, Gareis D, Muller KM, Seeber S and Schutte L: Low specificity of cytokeratin 19 reverse transcriptase polymerase chain reaction analysis for detection of hematogeneous lung cancer dissemination. J Clin Oncol 13: 2769-2775, 1995.
30. Traweek ST, Jiu J and Battifora H: Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 142: 1111-1118, 1993.
31. Glaves D, Huben R and Weiss L: Haematogenous dissemination of cells from human renal adenocarcinoma. Br J Cancer 54: 32-35, 1988.